中国神威药业集团有限公司（香港联交所股票代码：02877）于2026年4月30日发布4月股份变动月报，报告期为2026年4月。根据公告，公司本月法定/注册股本仍为5,000,000,000股，面值每股港币0.1元，总额港币500,000,000元。上述注册股本在4月无变动。
截至4月30日，公司普通股已发行股本为827,000,000股，与上月底保持一致，月内无任何新增发行、购回、注销或库藏股活动。公告显示，公司无股份期权或股权激励计划变动，亦无可换股票据、权证及其他类似合法授权的股份安排。
公司表示，已遵守香港联合交易所有限公司的相关上市规则及所有适用的法律和监管规定。公告由公司秘书李品正签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.